نتائج البحث 791-800 من 7580 لعملية البحث عن Managing Diabetes-Related Stress
... and blood samples) are predictors of treatment success. Gemini Study to Evaluate the Integration of Cancer Genetic Testing into a Cancer Clinical Practice ...
Accessed Sept. 14, 2023. Diabetes risk factors. Centers for Disease Control and Prevention. https://www.cdc.gov/diabetes/basics/risk-factors.html. Accessed Sept ...
This study is being done to store blood, buccal (cheek) cells, genetic material including DNA (deoxyribonucleic acid) and RNA (ribonucleic acid), and bone ...
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
... and extracted DNA, and evaluate ctDNA levels at baseline and during treatment for patients with Stage I-III breast cancer. Open-label, Multi-center, Phase ...
... and patients who have rhabdomyosarcoma with DNA mutations get separate treatment. ... A Study to Evaluate Immune-related Biomarkers for Pathological ...
Treating Breast Cancer Patients Undergoing Trastuzumab Treatment with Carvedilol to Reduce ... and blood samples) are predictors of treatment success. Gemini ...
Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help ...
... treatment with carboplatine/vincristine (CV) for subjects with NF1-associated low ... The purpose of this study is to determine and compare the safety and ...
The important improvements in CHD diagnosis and surgical treatment in the last decades has led to an increased survival of newborns affected with heart defects.
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.